tiprankstipranks
NervGen Pharma (NGENF)
OTHER OTC:NGENF
Holding NGENF?
Track your performance easily

NervGen Pharma (NGENF) Financial Statements

47 Followers

NervGen Pharma Financial Overview

NervGen Pharma's market cap is currently ―. The company's EPS TTM is $-0.271; its P/E ratio is -6.60; NervGen Pharma is scheduled to report earnings on April 30, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -7.83MC$ -2.35MC$ -8.61MC$ -4.30MC$ -5.03M
EBITDAC$ -7.81MC$ -2.31MC$ -8.57MC$ -4.27MC$ -4.99M
Net Income Common StockholdersC$ -7.83MC$ -2.35MC$ -8.61MC$ -4.30MC$ -5.03M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 26.56MC$ 30.30MC$ 11.66MC$ 14.79MC$ 16.08M
Total AssetsC$ 27.89MC$ 31.78MC$ 13.24MC$ 16.36MC$ 17.42M
Total DebtC$ 152.08KC$ 174.80KC$ 197.19KC$ 219.24KC$ 240.97K
Net DebtC$ -26.41MC$ -30.13MC$ -11.46MC$ -14.57MC$ -15.84M
Total LiabilitiesC$ 15.40MC$ 12.96MC$ 15.25MC$ 11.25MC$ 9.86M
Stockholders EquityC$ 12.49MC$ 18.83MC$ -2.01MC$ 5.11MC$ 7.56M
Cash Flow-
Free Cash FlowC$ -4.18MC$ -3.25MC$ -3.09MC$ -1.57MC$ -2.00M
Operating Cash FlowC$ -4.18MC$ -3.25MC$ -3.09MC$ -1.43MC$ -2.00M
Investing Cash FlowC$ 8.41K-C$ 1.00C$ -138.46KC$ -2.94K
Financing Cash FlowC$ 111.28KC$ 22.00MC$ 74.77KC$ 72.38KC$ 253.86K
Currency in CAD

NervGen Pharma Earnings and Revenue History

NervGen Pharma Debt to Assets

NervGen Pharma Cash Flow

NervGen Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis